Enterprise Value
308.5M
Cash
162.8M
Avg Qtr Burn
-16.76M
Short % of Float
3.92%
Insider Ownership
0.86%
Institutional Own.
84.79%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
TSC-203-A0201 Details Cancer, Solid tumor/s | Phase 1 Data readout | |
TSC-100 & TSC-101 Details Cancer, Hematologic malignancies | Phase 1 Data readout | |
TSC-203-A0201, TSC-200-A0201, TSC-204-A0201, TSC-204-C0702,TSC-201-B0702, TSC-204-A0101 Details Cancer, Solid tumor/s, Human papillomavirus | Phase 1 Data readout |